GlassScriptPhysician profile
Lynn N Ellington
NPI 1568454908
$4,337.40
in general payments reported to CMS, 2019-2025
30 companies · $880 in 2025
The $880 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $308 · 2021: $547 · 2022: $740 · 2023: $773 · 2024: $584 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.31 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $558.45 | 2023-2025 | Veozah |
| Abbvie INC. | $509.57 | 2019-2023 | |
| Pfizer INC. | $503.26 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $457.98 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $393.87 | 2021-2025 | |
| Biogen, INC. | $237.25 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $211.86 | 2019-2025 | Endosee, Paragard T 380a, Mara Console |
| Millicent US INC | $191.23 | 2022-2025 | Intrarosa, Femlyv, Femring |
| Exeltis, USA INC. | $184.83 | 2019-2025 | Slynd |
| Organon LLC | $138.97 | 2021-2022 | |
| Agile Therapeutics, INC. | $123.63 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $113.40 | 2019-2022 | |
| Avion Pharmaceuticals | $86.76 | 2019-2021 | |
| Channel Medsystems, INC. | $80.42 | 2022-2024 | |
| Lupin INC. | $76.63 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60.07 | 2019-2021 | |
| Minerva Surgical, INC | $54.32 | 2019-2025 | |
| Exact Sciences Corporation | $40.83 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $40.22 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.21 | 2019-2020 | |
| Shield Therapeutics INC | $33.80 | 2023-2024 | Accrufer |
| Duchesnay USA Incorporated | $31.60 | 2019 | |
| Hologic Sales and Service, LLC | $28.52 | 2019-2023 | Myosure Tissue Removal Device, Omni Hysteroscope |
| Meditrina | $27.29 | 2023-2025 | |
| Allergan, INC. | $25.29 | 2019-2020 | |
| Medtronic, INC. | $24.02 | 2022 | |
| Gynesonics, INC. | $22.54 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $14.25 | 2020 | |
| Sumitomo Pharma America, INC. | $13.89 | 2025 | Myfembree |
| Olympus America INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Ellington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.